Koers Kinder Holding Corp OTC Bulletin Board
Aandelen
US4945261067
Farmaceutische producten
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 2,29 mln. 2,12 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | - 0 | EV/omzet 2022 | - |
Nettoschuld 2022 | 105K 97,06K | Nettoschuld 2023 | 236K 219K | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-5,77
x | K/w-verhouding 2023 |
-6,16
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 41,45% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 75 | 01-02-14 | |
Evan Wasoff
DFI | Director of Finance/CFO | 77 | - |
Jeremy Reeh
CTO | Chief Tech/Sci/R&D Officer | - | 26-10-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lindy Snider
BRD | Director/Board Member | 64 | 26-01-18 |
Chief Executive Officer | 75 | 01-02-14 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+45,82% | 754 mld. | |
+40,95% | 630 mld. | |
-6,16% | 352 mld. | |
+19,86% | 331 mld. | |
+9,32% | 298 mld. | |
+18,45% | 250 mld. | |
+11,88% | 217 mld. | |
-0,78% | 216 mld. | |
+5,90% | 164 mld. |